Search results for Omalizumab

Omalizumab Biosimilar – Anti-IGHE mAb – Research Grade, ProteoGenix, PX-TA1055

Description of Omalizumab Biosimilar - Anti-IGHE mAb - Research Grade General information on Anti-IGHE(Homo sapiens) (Omalizumab) Monoclonal Antibody Omalizumab was sold to treat adults and children above 12 with persistent allergic asthma which is not controlled by inhaled steroids.

Omalizumab, Affinityimmuno, ab-131-omalizumab

Omalizumab, Abbexa, abx831021

Omalizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IGHE, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Omalizumab is a recombinant, humanized, monoclonal antibody against human immunoglobulin E (IgE).

Omalizumab Antibody, Abbexa, abx376605

Omalizumab Antibody is a rabbit polyclonal antibody for the detection of Omalizumab.

Anti-Omalizumab Polyclonal Antibody, AntibodySystem, PAJ92701

Anti-Omalizumab Antibody (SAb2319), AntibodySystem, RAJ92701

Omalizumab Biosimilar - Research Grade, ichor.bio, ICH4010

Detects human IgE. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Omalizumab.

Anti-Omalizumab Neutralizing Antibody ELISA kit, ProteoGenix, KPTX321

Description of Anti-Omalizumab Neutralizing Antibody ELISA kit Introduction The Anti-Omalizumab Neutralizing Antibody ELISA kit is a highly sensitive and specific assay designed for the detection and measurement of anti-omalizumab neutralizing antibodies in various biological samples. This kit is an essential tool for researchers and clinicians studying the therapeutic effects of omalizumab and its potential role in the treatment of various diseases. Structure of Anti-Omalizumab Neutralizing Antibody ELISA kit The Anti-Omalizumab Neutralizing Antibody ELISA kit is composed of several key components, including a microplate coated with omalizumab, a detection antibody, and a substrate solution. The microplate is pre-coated with omalizumab, which serves as the capture antibody for the target neutralizing antibodies. The detection antibody is specific for human IgG and is conjugated with an enzyme that produces a colorimetric signal upon binding to the captured antibodies. The substrate solution is added to the microplate and reacts with the enzyme-conjugated detection antibody, resulting in a color change that is directly proportional to the amount of neutralizing antibodies present in the sample. Activity of Anti-Omalizumab Neutralizing Antibody ELISA kit The Anti-Omalizumab Neutralizing Antibody ELISA kit is a highly sensitive and specific assay that can detect and quantify anti-omalizumab neutralizing antibodies in a variety of biological samples, including serum, plasma, and cell culture supernatants. This kit has a wide dynamic range, allowing for the detection of neutralizing antibodies at low concentrations. The assay has a high sensitivity, with a limit of detection of 0.1 ng/mL, making it suitable for the detection of even trace amounts of neutralizing antibodies. The activity of the Anti-Omalizumab Neutralizing Antibody ELISA kit is based on the principle of competitive ELISA. In this assay, the sample is first incubated with the microplate coated with omalizumab, allowing for the capture of any neutralizing antibodies present in the sample. The detection antibody is then added, which competes with the captured antibodies for binding to omalizumab. The amount of neutralizing antibodies present in the sample is inversely proportional to the color intensity, allowing for the quantification of neutralizing antibodies in the sample. Application of Anti-Omalizumab Neutralizing Antibody ELISA kit The Anti-Omalizumab Neutralizing Antibody ELISA kit has a wide range of applications in both research and clinical settings. It is an essential tool for researchers studying the therapeutic effects of omalizumab and its potential role in the treatment of various diseases, such as asthma, chronic urticaria, and allergic rhinitis. This kit can be used to measure the levels of neutralizing antibodies in patients receiving omalizumab therapy, providing valuable information on treatment response and potential drug resistance. In addition to its use in clinical research, the Anti-Omalizumab Neutralizing Antibody ELISA kit is also useful in the development and quality control of omalizumab-based therapeutics. It can be used to measure the neutralizing activity of candidate drugs and to ensure the consistency and potency of omalizumab-based products. Conclusion In summary, the Anti-Omalizumab Neutralizing Antibody ELISA kit is a highly sensitive and specific assay that serves as an essential tool for researchers and clinicians studying the therapeutic effects of omalizumab. Its ability to accurately detect and quantify anti-omalizumab neutralizing antibodies makes it a valuable tool for understanding the mechanisms of action of omalizumab and its potential role in the treatment of various diseases. This kit is also useful in the development and quality control of omalizumab-based therapeutics, making it a versatile and essential tool for the scientific community.

Anti-Omalizumab Non-Neutralizing Antibody (SAA2619), ProteoGenix, PTX27123